Praxis Precision Medicines, Inc. (PRAX)
342.71
+0.25
(+0.07%)
USD |
NASDAQ |
Feb 24, 16:00
342.00
-0.71
(-0.21%)
Pre-Market: 08:50
Praxis Precision Medicines Research and Development Expense (Quarterly) : 77.51M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Viridian Therapeutics, Inc. | 86.15M |
| Insmed, Inc. | 254.91M |
| Marker Therapeutics, Inc. | 2.346M |
| Protagonist Therapeutics, Inc. | 40.00M |
| Celcuity, Inc. | 34.92M |